Clinical stage, therapy, and prognosis in canine anal sac gland carcinoma

Journal of Veterinary Internal Medicine

Volumn 21, Issue 2, 2007, Pages 274-280

  Polton, Gerry A ^a   Brearley, Malcolm J ^a  

^a DAVIES VETERINARY SPECIALISTS   (United Kingdom)

Author keywords

Anal sac adenocarcinoma; Apocrine gland; Lymph node extirpation; Prospective study; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ALGORITHM; ANAL SAC; ANIMAL; ANIMAL DISEASE; ARTICLE; CLASSIFICATION; CLINICAL TRIAL; DOG; DOG DISEASE; FEMALE; MALE; NEOPLASM; PATHOLOGY; RADIOTHERAPY; RETROSPECTIVE STUDY; SURVIVAL RATE;

ALGORITHMS; ANAL SACS; ANIMALS; ANTINEOPLASTIC AGENTS; DOG DISEASES; DOGS; FEMALE; MALE; NEOPLASMS; RADIOTHERAPY; RETROSPECTIVE STUDIES; SURVIVAL RATE;

ANIMALIA; CANIS FAMILIARIS;

EID: 34047092280     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2007)21[274:CSTAPI]2.0.CO;2     Document Type: Article

References (16)

1. Withrow SJ. Perianal tumors. In: Withrow SJ, MacEwen EG, eds. Small Animal Clinical Oncology, 3rd ed. Philadelphia, PA: WB Saunders; 2001:346-353.
2. Goldschmidt MH, Hendrick MJ. Anal sac gland carcinoma. In: Meuten DJ, ed. Tumors in Domestic Animals, 4th ed. Ames, Iowa: Iowa State Press; 2002:74-76.
3. Williams LE, Gliatto JM, Dodge RK, et al. Carcinoma of the apocrine glands of the anal sac in dogs: 113 cases (1985-1995). J Am Vet Med Assoc 2003;223:825-831.
4. Ross JT, Scavelli TD, Matthiesen DT, Patnaik A. Adenocarcinoma of the apocrine glands of the anal sac in dogs: A review of 32 cases. J Am Animal Hospital Assoc 1991;27:349-355.
5. Bennett PF, DeNicola DB, Bonney P, et al. Canine anal sac adenocarcinomas: Clinical presentation and response to therapy. J Vet Intern Med 2002;16:100-104.
6. White RAS, Gorman NT. The clinical diagnosis and management of rectal and pararectal tumors in dogs. J Small Animal Pract 1987;28:87-107.
7. Turek MM, Forrest LJ, Adams WM, et al. Postoperative radiotherapy and mitoxantrone for anal sac adenocarcinoma in the dog: 15 cases (1991-2001). Veterinary and Comparative Oncology 2003;1:94-104.
8. Sobin LH, Wittekind CH. The history of the TNM classification system. In TNM Online. New York: John Wiley and Sons, 2005. Available at: http://www.mrw.interscience.wiley.com/tnm/tnmc/articles/tnmcOl/frame.html. Accessed February 22, 2006.
9. Owen LN. TNM Classification of Tumors in Domestic Animals. Geneva, Switzerland: World Health Organization; 1980:12-13.
10. Hahn KA, DeNicola DB, Richardson RC, Hahn EA. Canine oral malignant melanoma: Prognostic utility of an alternative staging system. J Small Animal Pract 1994;35:251-256.
11. Philibert JC, Snyder PW, Glickman N, et al. Influence of host factors on survival in dogs with malignant mammary gland tumors. J Vet Intern Med 2003;17:102-106.
12. Galea MH, Blarney RW, Elston CE, Ellis IO. The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 1992;22:207-219.
13. Dobson J, Morris J. Small Animal Oncology. Oxford, UK: Blackwell Science; 2001:15-30.
14. Hobson HP, Brown MR, Rogers KS. Surgery of metastatic anal sac adenocarcinoma in five dogs. Vet Surg 2006;35:267-270.
15. Altman DG. Practical Statistics for Medical Research. London, UK: Chapman and Hall; 1991:365-395.
16. Altman DG. Practical Statistics for Medical Research. London, UK: Chapman and Hall; 1991:74-106.